<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>53</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>20</volume><submitter>Cui M</submitter><pubmed_abstract>&lt;b>Objective:&lt;/b> To explore the function of the miR-18a-5p/CPEB3 axis in regulating the occurrence of hepatocellular carcinoma (HCC). &lt;b>Methods:&lt;/b> Differentially expressed miRNAs and mRNAs were acquired by bioinformatics analysis. qRT-PCR was used for miR-18a-5p and CPEB3 mRNA expression detection. Cell functional assays were implemented to examine the biological functions of HCC cells. The binding relationship between miR-18a-5p and CPEB3 was verified by a dual luciferase assay. &lt;b>Results:&lt;/b> In HCC, miR-18a-5p was remarkably highly expressed, while CPEB3 was markedly lowly expressed. HCC cell progression was facilitated after cells transfecting miR-18a-5p mimic, whereas silencing miR-18a-5p caused the opposite result. Overexpressing CPEB3 could restore promoting effect of miR-18a-5p on the growth of HCC cells. &lt;b>Conclusion:&lt;/b> Oncogene miR-18a-5p accelerates malignant phenotype by suppressing CPEB3. MiR-18a-5p/CPEB3 axis in HCC identified in this study provides a new target for HCC treatment.</pubmed_abstract><journal>Technology in cancer research &amp; treatment</journal><pagination>15330338211043976</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8573499</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3.</pubmed_title><pmcid>PMC8573499</pmcid><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Cheng D</pubmed_authors><pubmed_authors>Cui M</pubmed_authors><pubmed_authors>Qu F</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><view_count>53</view_count></additional><is_claimable>false</is_claimable><name>MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3.</name><description>&lt;b>Objective:&lt;/b> To explore the function of the miR-18a-5p/CPEB3 axis in regulating the occurrence of hepatocellular carcinoma (HCC). &lt;b>Methods:&lt;/b> Differentially expressed miRNAs and mRNAs were acquired by bioinformatics analysis. qRT-PCR was used for miR-18a-5p and CPEB3 mRNA expression detection. Cell functional assays were implemented to examine the biological functions of HCC cells. The binding relationship between miR-18a-5p and CPEB3 was verified by a dual luciferase assay. &lt;b>Results:&lt;/b> In HCC, miR-18a-5p was remarkably highly expressed, while CPEB3 was markedly lowly expressed. HCC cell progression was facilitated after cells transfecting miR-18a-5p mimic, whereas silencing miR-18a-5p caused the opposite result. Overexpressing CPEB3 could restore promoting effect of miR-18a-5p on the growth of HCC cells. &lt;b>Conclusion:&lt;/b> Oncogene miR-18a-5p accelerates malignant phenotype by suppressing CPEB3. MiR-18a-5p/CPEB3 axis in HCC identified in this study provides a new target for HCC treatment.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan-Dec</publication><modification>2024-12-04T04:33:11.943Z</modification><creation>2022-02-11T12:35:44.746Z</creation></dates><accession>S-EPMC8573499</accession><cross_references><pubmed>34738854</pubmed><doi>10.1177/15330338211043976</doi></cross_references></HashMap>